ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

GRFS Grifols SA

6,38
0,11 (1,75%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Grifols SA GRFS NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
0,11 1,75% 6,38 22:00:13
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,36 6,29 6,505 6,38 6,27
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
19/4/202422:42PRNUSGrifols 2023 Annual Report on Form 20-F filed with the SEC
18/4/202415:30GLOBEGrifols Celebrates 50 Years of Manufacturing Life-Changing..
15/4/202413:06IHMARKETNEWSSamsung Surpasses Apple in Q1 Smartphone Market; Salesforce..
04/4/202410:00GLOBEGrifols Procleix ArboPlex Assay® Receives CE Mark, the First..
22/3/202414:07IHMARKETNEWSFedEx Soars 13% with Profits Above Forecasts, Nike Hit by..
08/3/202412:19IHMARKETNEWSCNOOC Oil Field Discovery in South China Sea, Grifols Surges..
14/2/202409:16GLOBEGrifols announces positive topline phase 3 fibrinogen..
26/1/202423:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202411:02DJFRL'acquisition d'Inhibrx par Sanofi est logique - Citi
16/1/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202412:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
10/1/202419:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202414:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202412:21IHMARKETNEWSWall Street Highlights: Tesla Launches Restyled Model 3,..
09/1/202420:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202414:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202315:59DJNGrifols Shares Rise on $1.76 Billion Sale of 20% Stake in..
29/12/202315:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202315:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202311:00PRNUSGrifols launches new solution to facilitate pre-transfusion..
15/11/202314:00GLOBEGrifols Completes Cohort 1 in Clinical Study of Alpha-1 15%,..
06/11/202314:00GLOBEGigaGen Presents IND-Enabling Data and Phase 1 Trial..
02/11/202318:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202300:30GLOBEAraclon Biotech Presents Positive Final Results from Phase 2..
20/10/202314:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/10/202314:00GLOBEGigaGen Granted Expansion of Contract with US Department of..
28/9/202314:00GLOBEGigaGen Partners with the National Cancer Institute to..
01/8/202314:00GLOBEGrifols Accelerates Healthcare Innovation with Google..
27/7/202317:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/7/202314:15GLOBEGrifols Achieves Positive Topline Results From Phase 4 Study..
18/7/202314:00GLOBEGrifols Completes Enrollment in Phase 3 Study of Long-term..
13/7/202314:00GLOBEGrifols Meets Enrollment Target in Phase 3 Study of Two Dose..
15/6/202301:34DJNADRs End Higher, Grifols, Victrex Trade Actively
14/6/202312:44DJNGrifols Shares Rise on Potential Sale of Shanghai RAAS Stock..
11/5/202314:30GLOBEGrifols Launches AlphaID™ At Home, Enabling U.S. Consumers..
10/5/202301:31DJNADRs End Mostly Lower, Natura & Co. and Grifols Trade..

Dernières Valeurs Consultées

Delayed Upgrade Clock